LAURA DAVIDSON: Open Payments
NPI 1609151216 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 35 payments from 12 companies in 2025. Trend: 2023 $387 · 2024 $593 · 2025 $1,085
Food & beverage: $1,062Education: $23
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $236 |
| ABBVIE INC. | 9 | $207 |
| Novocure Inc. | 1 | $168 |
| Merck Sharp & Dohme LLC | 6 | $154 |
| Myriad Genetic Laboratories, Inc. | 1 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| PFIZER INC. | 2 | $51 |
| Gilead Sciences, Inc. | 2 | $48 |
| ARRAY BIOPHARMA INC | 1 | $21 |
| TAIHO ONCOLOGY, INC. | 1 | $19 |
Products named: Optune Lua (NovoTTF-200T), EPKINLY, KEYTRUDA, DATROWAY, MYRISK, KISQALI, Trodelvy, VENCLEXTA.
Industry payments across KS — which companies pay providers there.
